Drugs / Budesonide/Formoterol Fumarate
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04215848 | Apr 2020 → Oct 2021 | asthma | Hat Yai Medical Education Center | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Budesonide/Formoterol Fumarate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04215848 ↗ |
| Route | Inhaled | “Budesonide/Formoterol Fumarate 160 MCG-4.5 MCG Inhalation Powder” NCT04215848 ↗ |